Overuse of imaging adds to rising healthcare costs

Article

A lengthening roster of digital imaging modalities, duplicative use of new and older technologies, and growing consumer demand are driving up U.S. healthcare costs significantly, according to a report released Oct. 15 by the Blue Cross and Blue Shield

A lengthening roster of digital imaging modalities, duplicative use of new and older technologies, and growing consumer demand are driving up U.S. healthcare costs significantly, according to a report released Oct. 15 by the Blue Cross and Blue Shield Association (BCBSA).

The report said U.S. diagnostic imaging costs are expected to reach as high as $100 billion annually by 2005, up from about $75 billion just three years ago.

The Blues say their companies across the country are developing innovative collaborations with physicians and hospitals that focus on the most efficient use of high-cost medical technology while safeguarding access to needed services.

"While diagnostic imaging technology is one the most important advancements to healthcare in the past quarter-century, it is also the most expensive technology," said Dr. Allan Korn, BCBSA's chief medical officer.

One of the critical questions before healthcare is how to ensure access to this technology while keeping it affordable, he said.

According to the report, demand may be driven in part by the development of better, less invasive technology. Consumer demand for new technology is high even when it is not clinically indicated.

While more new procedures and modalities are added to the healthcare system, older procedures and equipment are not replaced. Increasing costs and utilization of these new technologies, coupled with growth in older technologies such as x-rays and ultrasound, suggest duplicative use, the report said.

There is also a strong incentive to perform more tests to help pay for the high initial cost of the newer technology.

The American College of Radiology generally concurred with the report, stating in response, "We agree with the conclusion stated in this publication and are currently engaged in collaborative efforts with major private and public payers to evaluate new imaging technology ... and educate referring physicians and patients about appropriate utilization of diagnostic imaging examination."

The ACR added that there has recently been a striking increase in the number of complex, high-cost imaging exams performed by nonradiologists, a trend driven by suppliers who are developing and marketing imaging equipment for use in nonradiologist physician offices.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.